RVAC Medicines Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

RVAC Medicines is an mRNA platform company with a pipeline of novel products covering a wide range of disease areas. The company is building a pipeline of novel mRNA vaccines and therapeutics to address unmet medical needs, particularly in emerging markets. It's cutting-edge GMP manufacturing facilities that will advance its platform technologies through in-house research and development and external partnerships, enabling the production of cutting-edge mRNA and nucleic acid delivery technologieView more